C6ORF32, AN HDAC6-BINDING PROTEIN THAT REGULATES MYOBLAST DIFFERENTIATION

C6ORF32，一种调节成肌细胞分化的 HDAC6 结合蛋白

• 批准号: 8185253
• 负责人: EMANUELA GUSSONI
• 金额: $ 39.08万
• 依托单位: BOSTON CHILDREN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-07-15 至 2016-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8185253
• 关键词: Ablation; Acetylation; Affect; Binding; Binding Proteins; Cell Communication; Cell Nucleus; Cell fusion; Cells; Computer Analysis; Cytoplasm; Cytoskeleton; Data; Defect; Development; Down-Regulation; Event; Future; Gene Expression; Gene Proteins; Genes; Genetic Transcription; Giant Cells; Goals; HDAC6 gene; Histone Deacetylase; Histones; Homeostasis; Human; In Vitro; Laboratories; Lysine; Messenger RNA; Metabolism; Mononuclear; Muscle; Muscle Cells; Muscle Development; Muscle Fibers; Myoblasts; Myogenin; Names; Natural regeneration; Nuclear; Pathway interactions; Play; Process; Protein Family; Proteins; Regulation; Reporting; Role; Screening procedure; Skeletal Muscle; Stem cells; Tissues; Transcript; Transcription Coactivator; Transcription Repressor/Corepressor; Tubulin; Work; Yang; cell motility; computerized data processing; fetal; in vivo; in vivo Model; injured; progenitor; protein activation; repaired; transcription factor; trophoblast

DESCRIPTION (provided by applicant): Skeletal muscle is comprised of multinucleated syncytia formed by the fusion of myoblasts. Through microarray studies, it was found that expression of C6ORF32 is upregulated early during human myoblast fusion, when myotubes contain between 2-5 myonuclei (Cerletti et al., 2006). Downregulation of C6ORF32 expression causes a block in myoblast fusion due to a significant decrease in myogenin expression (Yoon et al., 2007). By computational analyses, the predicted C6ORF32 protein contains only one domain of known function, a putative HDAC-binding domain. It was found that C6ORF32 binds to HDAC6, a class IIb HDAC known for its function in promoting cell motility. It is hypothesized that HDAC6 and C6ORF32 are functionally connected, and the interaction between HDAC6 and C6ORF32 positively regulates myogenic differentiation by reducing the de-acetylation activity of HDAC6. The regulatory connection between HDAC6 and C6ORF32 in skeletal muscle will be studied both in vitro and in vivo via the following specific aims: 1) Define the critical binding region of C6ORF32 to HDAC6, and demonstrate that binding of these two proteins occurs in vivo; 2) Determine if HDAC6 regulates myoblast differentiation by modulating C6ORF32 acetylation/de-acetylation; 3) Evaluate if C6ORF32 regulates myoblast differentiation by modulating HDAC6 activity; 4) Determine if ablation of C6ORF32 expression in vivo yields to defects in muscle development, function and regeneration by affecting HDAC6 function. These studies will constitute the groundwork for understanding whether future pharmacological therapies targeting the regulatory interaction between C6ORF32 and HDAC6 are amenable to enhance myogenic repair. PUBLIC HEALTH RELEVANCE: C6ORF32 is an unnamed protein upregulated during fusion of human myoblasts. Previous studies in our laboratory have indicated that C6ORF32 might be involved in myogenic differentiation. More recent data indicates that C6ORF32 binds HDAC6, a critical HDAC known to regulate cell motility and cell-cell interactions. The current application will dissect the regulatory connection between HDAC6 and C6ORF32, and how this connection affects myogenic differentiation. This goal will be achieved through in vitro and in vivo studies. The proposed work will open the possibility of modulating the HDAC6-C6ORF32 regulatory interaction to enhance muscle cell fusion, with the broader scope of using C6ORF32 as a new target for muscle repair.

描述（由申请人提供）：骨骼肌由成肌细胞融合形成的多核合胞体组成。通过微阵列研究，发现在人成肌细胞融合早期，当肌管包含 2-5 个肌核时，C6ORF32 的表达上调（Cerletti 等，2006）。 C6ORF32 表达的下调会由于肌细胞生成素表达显着降低而导致成肌细胞融合受阻（Yoon 等，2007）。通过计算分析，预测的 C6ORF32 蛋白仅包含一个已知功能的结构域，即假定的 HDAC 结合结构域。研究发现，C6ORF32 与 HDAC6 结合，HDAC6 是一种 IIb 类 HDAC，因其促进细胞运动的功能而闻名。假设HDAC6和C6ORF32在功能上相连，并且HDAC6和C6ORF32之间的相互作用通过降低HDAC6的去乙酰化活性来正向调节肌原性分化。将通过以下具体目标在体外和体内研究骨骼肌中 HDAC6 和 C6ORF32 之间的调控联系： 1）定义 C6ORF32 与 HDAC6 的关键结合区域，并证明这两种蛋白的结合发生在体内； 2)确定HDAC6是否通过调节C6ORF32乙酰化/去乙酰化来调节成肌细胞分化； 3) 评估C6ORF32是否通过调节HDAC6活性来调节成肌细胞分化； 4) 确定体内 C6ORF32 表达的消除是否会通过影响 HDAC6 功能而导致肌肉发育、功能和再生缺陷。这些研究将为了解未来针对 C6ORF32 和 HDAC6 之间的调节相互作用的药物疗法是否能够增强肌源性修复奠定基础。 公共健康相关性：C6ORF32 是一种在人类成肌细胞融合过程中上调的未命名蛋白质。我们实验室先前的研究表明C6ORF32可能参与肌原性分化。最近的数据表明，C6ORF32 结合 HDAC6，这是一种已知调节细胞运动和细胞间相互作用的关键 HDAC。当前的申请将剖析 HDAC6 和 C6ORF32 之间的调节联系，以及这种联系如何影响肌源性分化。这一目标将通过体外和体内研究来实现。拟议的工作将开启调节 HDAC6-C6ORF32 调节相互作用以增强肌肉细胞融合的可能性，并更广泛地使用 C6ORF32 作为肌肉修复的新靶点。